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Background. We developed a completely closed system based on gravity separation without centrifugation steps for separation
of whole blood. With this new system we compared quality and stability of the processed blood components (PRC and plasma)
with respect to classical preparation. Furthermore the cost-eﬀectiveness of this hollow ﬁbre system was evaluated. Study Design
and Methods. Whole blood collections of 15 regular blood donors were used for component preparation using the U shaped
hollow ﬁbre ﬁlter device. Results were compared to 15 whole blood preparations using centrifugation. The following parameters
were evaluated: total hemoglobin, leukocyte counts, the serum concentration of total protein, lactate dehydrogenase (LDH) and
potassium. Furthermore ATIII, vWF and F VIII were analyzed at diﬀerent timepoints. Results. packed red cells: the data directly
after separation and after 42 days of storage are in line with the guidelines of the council of Europe. Plasma. all plasma quality data
are in line with the guidelines of the council of Europe for quality assurance of plasma, except for a low protein amount (factor
0.75). Conclusion. Separation of whole blood on a clinical scale in this new closed system is feasible, however the plasma protein
content must be optimized.
Copyright © 2009 T. Brune et al.ThisisanopenaccessarticledistributedundertheCreativeCommonsAttributionLicense,which
permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
1.Introduction
Separation of whole blood into the diﬀerent blood compo-
nents is a standard procedure in transfusion medicine. This
separation is either performed by centrifugation using pro-
grammable centrifuges and automated blood-component
preparation systems after collecting whole blood or during
the collection of blood in the case of cellular apheresis.
In both cases an extensive infrastructure (central facility,
expensive equipment, and well-trained staﬀ)i sr e q u i r e d
for the successful processing of the blood. Besides the
necessary equipment, labor-intensive manual processes are
necessary in the case of whole blood separation or careful
supervision of the apheresis process in the case of cellular
apheresis.Weinvestigatediftheabove-mentionedseparation
methodologies could be replaced by a closed-system gravity
ﬁltration.
There were several attempts to replace the centrifugation
and additional separation method using simple gravity
ﬁltration. The ﬁrst study on the separation of whole blood to
PRCs and plasma using a hollow-ﬁbre system was performed
by Sekiguchi et al. [1]. By changing the ﬁlter systems,
integrating leukocyte ﬁlters and using a storage medium
for extended storage, diﬀerent authors were able to show
that it is possible to process PRCs and plasma using gravity
separation with comparable quality and stability data to
those processed by classic centrifugation/apheresis methods.
Nevertheless, the problem with these ﬁrst attempts was
the low concentration ability of the ﬁlter system with a
resulting low HCT in the PRCs and a reduced plasma
recovery. This low concentration ability mainly results from
the relatively high ﬂow rate through the linear ﬁlter system
[2–5] preventing an eﬀective separation into plasma and
cellular components.2 Advances in Hematology
Table 1
Parameter Analyzer
Free Hemoglobin: Analyzer Low Hemoglobin, Hemocue
Hematology: Cell-Dyn 4000 and CellDyn 350, Abbott, USA
Total-Protein, Serum LDH, Serum potassium: AU 640/AU 2700, Olympus
Von-Willebrand-Antigen: Mini-VIDAS, Biomerieux, Paris, France
Fibrinogen, F VIII: BCT, Dade Behring, Marburg, Germany
Residual leucocytes: Epics XL, Coulter, USA
Table 2: Donors, initial values.
N = 15 Hb (g/dL) Leukocytes
(103/µL)
Total Protein
(g/L) LDH (U/L) K+ (mmol/L) AT III
(% o. N.)
vWF-Antigen
(% o. N.)
F VIII
(% o. N.)
Mean ± SD 13.8 ± 1.1 5.2 ± 1.5 70 ± 4 176 ± 42 4.1 ± 0.2 104 ± 11 86 ± 24 98 ± 28
Range 11.2–15.2 3.5–8.5 62–77 122–290 3.7–4.7 93–119 58–118 57–149
To improve the separation potential a new hollow-ﬁbre
system was designed with hollow ﬁbres enclosed in a plastic
casting in the shape of a stirrup (U shape), which was
separated, by polyurethane, into compartments for plasma
(outside the capillaries) and red cells (within the ﬁbres).
Details of the hollow-ﬁbre ﬁlter are given in Figure 1. This
preliminary ﬁlter design was incorporated into a blood sepa-
ration device and was tested by Heim [6], Stienstra et al. [7],
and Hornsey et al. [8]. They concluded that whole blood
separation using the hollow-ﬁbre technique is simple and
straightforward to use; however, minor changes are required
to make the procedure easier to incorporate into routine use.
Based upon the practical experience of Hornsey we
modiﬁed the original hollow-ﬁbre device in an attempt to
improve its performance.
In the preliminary system evaluated by Hornsey et al.
the ﬁlter system and the donation bag were separate and the
hollow ﬁbre system was dry. A Pall leukocyte ﬁlter was used
for leukocyte depletion. Before separation the hollow-ﬁbre
ﬁlter had to be moistened carefully with sodium chloride
and the donation bag had to be sealed sterile to the blood
donation bag. Based on the experience with this preliminary
system we developed a complete integral pack closed system
containing anticoagulant and an additive solution attached
directly to the device and with ﬁlters premoistened with
sodium chloride. In addition, we replaced the Pall leukocyte
depletion ﬁlter by a Fresenius leukocyte depletion ﬁlter. In
the present study we present the quality and stability data
of PRCs and plasma which were processed with this new
clinicalsystem.Toevaluatethepossiblecost-eﬀectiveness,we
compared both systems with respect to hands-on time.
2. Donors, Material,and Methods
2.1. Donors. 15 donors were stochastically selected from
regular blood donors of the Department of Transfusion
Medicine, Marienkrankenhaus, Hamburg, Germany. All
donors were informed about the clinical trial and the use
of the donated blood. All participating donors gave their
informed consent.
2.2. Blood Collection. All blood donations were performed
according to the standard guidelines for blood donations
in Germany. In each donor the following parameters were
measured: total hemoglobin (Hb), leukocyte count, the
serum concentrations of total protein, lactate dehydrogenase
(LDH), and potassium. Furthermore, the activities of the
coagulation factors antihrombin III (AT III), von Willebrand
factor (vWF), and factor VIII (F VIII) were analyzed. The
analyzers we used for these investigations are presented
in Table 1. All measurements were performed according to
the recommendations of the manufacturers of the analyzers
used.
After careful desinfection and successful punction of the
cubital vein we collected 450mL blood from each donor
using the integrated hollow-ﬁbre system. During the blood
collection the donation bag was placed on a standard blood-
mixing device (NPBI Compomixer M2). Immediately after
the blood collection the inlet tubing of the donation bag was
sterile sealed.
2.3. Blood Separation. Before blood separation the donated
whole blood unit was left to rest at ambient temperature
(about 20◦C) for 2 hours in order to allow phagocytosis for
free bacteria. The details of the closed hollow-ﬁbre sepa-
ration system are given in Figure 2. The gravity-separation
procedure is performed as follows. First the donation bag
containing 63mL CPD (1000mL of CPD contains 3.27g
of citric acid·H2O, 26.3g of sodium citrate·2H2O, 25.5g of
glucose·H2O, and 2.51g of NaH2PO4·H2O) is hung on the
upper hook of the main stand (b). Then the packed red
cells (PRCs) bag (c) preﬁlled with extended storage medium
(100mLPAGGS-M)(1000mLofPAGGS-Mcontains9.400g
of glucose·H2O, 1.255g of NaH2PO4·H2O, 1.432g of
NaHPO4·H2O, 0.194g of adenine, 0.408g of guanosine,
10.000gofmannitoland4.210gofsodiumchloride)andthe
separation ﬁlter (d) is hung on the middle attachments both
exactly on the same level. After all clamps and inline break
valves have been opened the blood ﬂows from the donation
bag through the leukocyte ﬁlter (e) and subsequently into
the hollow-ﬁbre system. While the leukocyte-depleted bloodAdvances in Hematology 3
Table 3
(a) Packed red cells directly after preparation.
N = 15 Volume
(mL)
Hb
Concen-
tration
(g/dL)
Hb/Unit
(g) Hct (%)
Residual
Leuko-
cytes/Unit
(×106)
Residual
Pro-
tein/Unit
(g)
K+ in
Super-
natant
(mmol/L)
K+/Unit
(mmol)
Free Hb
(g/L)
LDH in
Super-
natant
(U/L)
Mean ± SD 346 ± 19 17.4 ± 1.2 60 ± 65 4 ± 4 0.03 ±
0.00 3.3 ± 0.8 1.8 ± 0.2 0.28 ±
0.04 <0.03 346 ± 19
Range 326–402 14.3–19.0 47–73 43–59 0.03–0.04 2.0–4.9 1.4–2.0 0.21–0.32 <0.03 25–73
(b) Packed red cells after 42 days of storage
N = 10 Free Hb (g/L) Lysis rate
Mean ± SD 1.21 ± 0,33 0.69 ± 0.16
Range 0.8–1.7 0.5–0.9
Table 4: Requirements for PRC.
Parameters Requirement Observations
Haemoglobin
im PRC
≥40 g/Unit 47–75 g/Unit
Residual
Leukocytes in
PRC
<1 × 106/Unit <0.05 × 106/Unit
No Leakage No Leakage
Visual
Examination
No Agglutination No Agglutination
No Change of Color No Change of Color
is slowly running through the inner space of the U-shaped
hollow ﬁbres the plasma is diﬀusing through the porous
walls with the result that the blood is separated into plasma
and erythrocytes. The blood ﬂow can be regulated via a
roller clamp, and the ﬂow rate was regulated via a drip
chamber. The cell-free plasma ﬂows down into the plasma
bag (f) and the erythrocytes to the erythrocytes bag. After
approximately 40 minutes the separation is ﬁnished. After
completion of the separation the PRC bag and the plasma
bagweresealedanddisconnectedfromtheseparationset.All
plasma preparations were frozen immediately and stored at
−30◦C (Blood Plasma Freezer: UF 40-300S, Colora GmbH,
Lorch, Germany). For quality control testing of the PRCs
we performed an automatic blood cell count and the free
hemoglobin concentration was measured. The hemolysis
rate was calculated according to the formula (100 – Hct)
× free HB/Hb. After processing the 15 PRCs were stored
for 42 days at +4◦C in a regular blood bank refrigerator
(Blood Bank Refrigerator BL-720, Philipp Kirsch GmbH,
Oﬀenburg, Germany) After 42 days of storage all quality
controls described above were repeated in the PRCs and
sterility control was performed. For quality control testing of
the plasma, concentrations of total protein, LDH, potassium
and ﬁbrinogen and also the residual leukocytes count were
performed.Inaddition,theactivityofthecoagulationfactors
AT III, vWF, and F VIII was determined. The plasma was
frozen at −30◦C according to a standard protocol. After 366
Packed
red cells
Whole
blood
U-shaped hollow
ﬁber capillaries
(a) Hollow-ﬁbre ﬁlter (ﬁlter cylin-
der opened for better view)
Packed
red cells
Whole
blood
Filter
cylinder
Plasma
(b) Hollow-ﬁbre ﬁlter ﬁxed within
the synthetic ﬁlter cylinder
Figure 1: Figures 1(a) and 1(b) show the hollow-ﬁbre ﬁlter in more
detail. Each hollow-ﬁbre ﬁlter is made of 600 capillary membranes,
producedfrompolyethersulfonwithathicknessof100µm ±25µm.
ThecapillariesareU-shaped(Figure 1(a))ﬁxedwithinthesynthetic
ﬁlter cylinder (Figure 1(b)) and moistened with a sodium chloride
solution. The capillaries have a pore size of 0.5µm ± 0.1µm. The
total length of the capillary amounts to 175.5m with a diameter
of 300µm ± 40µm. The hydrostatic pressure of the donation bag
ﬁxed above the ﬁlter is enough to press the erythrocytes into
the erythrocytes bag. During the separation process the plasma
penetrates the capillary membranes, is sampled in the ﬁlter cylinder
and ﬂows down to the plasma bag. Because of the cells’ volume the
erythrocytes are not ableto penetrate themembrane and ﬂow along
the U-shaped capillary to the upper exit in the erythrocytes bag
hung at the same height and preﬁlled with the 100mL PAGGS-M
additive solution.
days of storage the frozen plasma was thawed and F VIII
activity was measured again.
2.4. Cost-Eﬀectiveness . To compare the presented method of
blood separation by gravity with the classic method using
whole blood and centrifugation as to its cost-eﬀectiveness,
we analyzed the hands-on time of each work step in both4 Advances in Hematology
Table 5
(a) Plasma directly after preparation.
N = 15 Volume
(mL)
Total
Protein
Concen-
tration
(g/L)
Total Pro-
tein/Unit
(g)
Residual
Leuko-
cytes/Unit
(×106)
Fibrinogen
(mg/dL)
Fibrinogen/
Unit (mg)
AT III
(% o. N.)
vWF-Antigen
(% o. N.)
FV I I I
(% o. N.)
Mean ± SD 234 ± 12 51 ± 4 12.0 ± 1.2 0.02 ±0.00 191 ± 41 450 ± 109 82 ± 98 2 ± 27 82 ± 27
Range 214–253 44–58 9.7–14.6 0.02–0.03 138–264 304–663 67–95 52–119 46–115
(b) Plasma F VIII after 366 days of storage.
N = 15 F VIII (% o. N.) % of activity before storage
Mean ± SD 57 ± 21 78 ± 5
Range 35–97 69–88
Table 6: Plasma electrophoresis directly after preparation.
Results Reference values
Total protein 58g/L 60–80g/L
Albumin 57% 55–67%
Alpha 1 Globulin 2.7% 2.1 –3.7%
Alpha 2 Globulin 9.4% 8.0–14.0%
Beta Globulins 10.8% 8.0–13.0%
Gamma 20.1% 9.0–20.0%
procedures (Centrifugation/Separation n = 6; Separation by
gravity n = 3). Only the real blood processing time was
included in the evaluation; the blood sampling time is the
same for both methods and was therefore not considered.
3. Results
3.1. Donor Parameters. The results of the donors’ blood
parameters are given in Table 2.
3.2.Packed Red Cells. The quality data of the processed PRCs
directly after separation are given in Table 3(a). After 42 days
of storage the content of free Hb was 1.2g/L (range: 0.8g/L
± 1.7g/L), which corresponds to a mean lysis rate of 0.7%
(range: 0.5%–0.9%) (Table 3(b)). All values are in line with
the guidelines of the Council of Europe [9] for the quality of
PRCs(Table 4).TheHCTofthePRCdirectlyafterseparation
can be calculated from the mean total volume (346mL) and
the mean HCT (0.54) of the PRCs and the knowledge of
the added SAG-M amount according the formula 346mL ×
0.54/(346mL–100mL) = 0.76. The donor’s original HCT of
0.43 is diluted by 63ml CPDA in the primary bag to an HCT
of 0.37(450 × 0.43/(450 + 63)). Based on these values the
calculated concentration ability of the ﬁlter is 76/37 = 2.05.
3.3. Plasma. The quality data of the plasma preparations
are given in Table 5(a). The protein content is reduced by
a factor of about 0.75 compared to the values of the initial
donor blood (Table 1). The plasma activity of antihrombin
(a)
(b)
(e)
(d) (c)
(f)
(b)
Figure 2: Complete gravity-separation system. (a) Donation bag
preﬁlled with 63mL CPD, (b) Mean stand, (c) Erythrocyte bag
preﬁlled with 100mL extended storage medium (PAGGS-M), (d)
Hollow-ﬁbre ﬁlter, (e) Leukocyte ﬁlter, (f) Plasma bag.
III, von Willebrand factor, and factor VIII correlates to the
protein content reduction and was approximately 0.8. The
residual leukocyte count in the plasma was at the lower
detection limit (below 2000/unit) and the plasma contained
no measurable free hemoglobin. The factor VIII activity
after one year of storage was 0.57 with a range of 0.35–
0.97 (Table 5(b)). This corresponds to 0.78 of the activity
before storage (range: 0.69–0.88). Serum electrophoresis of
randomly selected plasma shows a normal protein fraction
distribution within the reference values (Table 6). All plasma
quality data are in line with the guidelines of the Council ofAdvances in Hematology 5
Table 7: Requirements for plasma preparations.
Parameters Requirement Observations
Volume ﬂuctuation of plasma preparations −10%··· +10% −7.8%···+9.0%
Residual leukocytes in plasma <1 × 106/Unit <0.04 × 106/Unit
No leakage No leakage
Visual examination No agglutination No agglutination
No change of color Clear, unclouded, amber coloured plasma
Table 8: Comparison of the mean processing times of the classical separation method and gravity separation.
Process activity Centrifugation Gravity Separation
Transport of the blood bags to the lab 2 min 2 min
Preparation of the leucocytes depletion 4 min
Leukocytes depletion 15 min
Preparation of the centrifugation step (cooling) 5 min
Centrifugation 20 min
Preparation of the blood separator 4 min
Separation of the whole blood to PRC and Plasma 12 min
Documentation 3m i n
Preparation of the PRC and Plasma for storage 5 min
Preparation of the gravity Separation ﬁlter system 4 min
Gravity separation 45 min
Documentation 3m i n
Preparation of the PRC and Plasma for storage 5 min
Sum 70 min 57 min
Minus centrifugation, respectively. gravity separation time (technician is free to perform other things) 20 min 45 min
Time technician is required for the processing 50 min 12 min
Europe for the quality assurance of plasma (Table 7), except
for the low protein amount.
3.4. Cost-Eﬀectiveness . The analysis and comparison of the
diﬀerent steps of both ways of whole blood processing are
given in Table 8 with the time necessary for a certain step
given in minutes. This table shows that the processing of
wholebloodintoPRCsandplasmatakesatotalof70minutes
with the centrifugation/separation method and 57 minutes
with the gravity-separation method. Both the centrifugation
process and the gravity-separation process themselves are
independent of a technologist and are times in which the
technologistscanperformothertasks.Wethereforepostulate
that a technologist is needed for 50 minutes using the classic
method and only 12 minutes using the gravity-separation
method.
4. Discussion
Our study demonstrates that whole blood can be sep-
arated eﬃciently into its components using a gravity-
driven completely closed hollow-ﬁbre system. The quality
and the stability of the PRCs and plasma thus processed
are comparable to the quality and the stability of blood
components processed in the classic way and correspond to
the German and European guidelines for the preparation,
use and quality assurance of blood components. However,
the protein concentration of the processed plasma is still
too low. The reasons for this protein loss are not completely
understood. We speculate on an interaction of the plasma
protein with the capillary membranes of the hollow ﬁbre
(polyethersulphone) causing absorption of plasma protein.
Taking into account that the total free length of the hollow
ﬁbre is 175.5m, minimal absorption could lead to a mea-
surable diﬀerence in plasma protein. A second mechanism
could be by activation of the coagulation system (platelet
activation?) due to contact with the artiﬁcial surface of the
hollow ﬁbre. Again this activation of the coagulation system
might be minimal, but the total surface of the hollow ﬁbre
system could make the diﬀerence. We plan to work on
these aspects by chemically modifying the surface of the
hollowﬁbrestoinhibitadsorptionoractivation.Thehollow-
ﬁbre ﬁlter blood-separation device eliminates the need for
either centrifugation or automated separation steps during
the processing of whole blood into red cells and plasma
components. A source of electrical power is not required
and the closed system can be used anywhere, irrespective
of environmental conditions. This means that an integral
system for safe blood collection and processing is also
within reach of under-resourced countries. However, other
applications are focussed upon as well. Blood collections
obtained at remote blood drives can be processed during
the actual blood drive locally without the need for a speedy6 Advances in Hematology
return to a central facility. The handling of the system is
easy and handy in practice. The net working time for
processing the blood components is lower compared to the
centrifugation method, only requiring a small number of
staﬀ and no large, specialized machines. Only a heat melting
clamp or clamping tongs for closing the tubes, a tubing roller
and the usual cooling and freezing equipment are necessary
for the production of the preparations from donor blood
described above.
The system has been in clinical use in diﬀerent countries
(Turkey, South Africa, and Mozambique, among others) for
2 years. To the authors’ best knowledge no adverse eﬀects
related to the separation system have been observed.
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